Suppr超能文献

源自结核分枝杆菌和牛分枝杆菌的结核菌素纯蛋白衍生物制剂的效价。

Potency of PPD preparations derived from M. tuberculosis and M. bovis.

作者信息

Zsidai J, Csizér Z, Joó I

出版信息

Ann Immunol Hung. 1979;19:63-74.

PMID:121875
Abstract

No significant difference was found between the biological activity of PPD-preparations derived from M. tuberculosis and M. bovis, although the latter was more potent. In potency tests performed in guinea-pigs, the use of difference mycobacteria as sensitizing agents had no influence on the result of the assay. We could not demonstrate a significantly greater potency of homologous versus heterologous PPD. Evaluation of the 95 p.c. fiducial limits established in the course of variance analysis suggested a greater reliability of reading at 48 than at 24 hrs after allergen application. It also seems possible that the results of the potency assays of PPDs derived from different mycobacterium strains are greatly influenced by the level of the working dilutions employed.

摘要

源自结核分枝杆菌和牛分枝杆菌的结核菌素纯蛋白衍生物(PPD)制剂的生物活性之间未发现显著差异,尽管后者效力更强。在豚鼠身上进行的效价测试中,使用不同的分枝杆菌作为致敏剂对测定结果没有影响。我们无法证明同源PPD比异源PPD具有显著更高的效力。对方差分析过程中确定的95%置信限的评估表明,在应用变应原后48小时读数比24小时更可靠。不同分枝杆菌菌株来源的PPD效价测定结果似乎也很可能受到所用工作稀释度水平的极大影响。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验